Prof. dr hab. Natalia Marek-Trzonkowska is the director of the International Centre for Cancer Vaccine Science (ICCVS) at the University of Gdańsk. Research led by Prof. Marek-Trzonkowska focuses on clinical application of the immune system cells. She is the author of numerous publications and patents, including the first application of regulatory T cells (Tregs) in the treatment of type 1 diabetes in children. Currently, she is working on cellular therapy for non-small cell lung cancer. She is interested in intercellular communication, immune tolerance and translational immunology. She is a recipient of the Kościuszko Foundation’s award, the Scholarship of the Minister of Science and Higher Education for Outstanding Young Scientists, and the Award of the Minister of Education and Science for Significant Achievements in Implementation Activities. Her research has been recognized with numerous awards granted by national and international organizations, including the Polish- American Medical Society, the Polish Academy of Sciences, the International Society for Pediatric and Adolescent Diabetes (ISPAD), the European Federation of Immunological Societies (EFIS), and the International Islet and Pancreas Transplantation Association (ISPAD).